Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UNG | P13051 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.43 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.43 |
| ▸ | SRC | P12931 | 1/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.39 |
| ▸ | BRD4 | O60885 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | TTR | P02766 | 2/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27293500 | 0.82 | UNG (0.68) | UNGALDH1A1TRIM24TRIM33SRC | |
| SCHEMBL9333647 | 0.82 | TDP1 (0.52) | UNGALDH1A1PTGS2TTRL3MBTL1 | |
| SCHEMBL28241938 | 0.82 | UNG (0.38) | UNGTTRL3MBTL1TDP1TSHR | |
| SCHEMBL29957449 | 0.82 | UNG (0.68) | UNGALDH1A1TRIM24TRIM33SRC | |
| SCHEMBL1482839 | 0.82 | UNG (0.68) | UNGALDH1A1TRIM24TRIM33SRC | |
| SCHEMBL19737184 | 0.80 | UNG (0.60) | UNGALDH1A1TRIM24TRIM33SRC | |
| SCHEMBL1745723 | 0.78 | UNG (0.63) | UNGALDH1A1TRIM24TRIM33SRC | |
| SCHEMBL167439 | 0.78 | FURIN (0.43) | L3MBTL1TDP1TSHRHTTLMNA | |
| SCHEMBL29001430 | 0.77 | UNG (0.56) | UNGALDH1A1TRIM24TRIM33SRC | |
| SCHEMBL6853599 | 0.77 | UNG (0.73) | UNGALDH1A1TRIM24TRIM33SRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113372877-A | Modified lignin-based adhesive and preparation method thereof | 深圳市洪欣巨供应链有限公司 | 2021-09-10 | — | — | CN | claimed |
| CN-113372877-A | Modified lignin-based adhesive and preparation method thereof | 深圳市洪欣巨供应链有限公司 | 2021-09-10 | — | — | CN | disclosed |
| CN-113372877-A | Modified lignin-based adhesive and preparation method thereof | 深圳市洪欣巨供应链有限公司 | 2021-09-10 | — | — | CN | disclosed |
| US-20170247688-A1 | ENZYMATIC ENCODING METHODS FOR EFFICIENT SYNTHESIS OF LARGE LIBRARIES | NUEVOLUTION A/S (DK) | 2017-08-31 | — | — | US | disclosed |
| US-20120323002-A1 | IMIDAZOPYRIDAZINE COMPOUNDS | AJINOMOTO CO., INC. (JP) | 2012-12-20 | — | — | US | disclosed |
| US-8314098-B2 | Pyrazolo-pyrimidine compounds | AJINOMOTO CO., INC. (JP) | 2012-11-20 | — | — | US | disclosed |
| EP-2518072-A1 | IMIDAZOPYRIDAZINE COMPOUNDS | AJINOMOTO CO., INC. (JP) | 2012-10-31 | — | — | EP | disclosed |
| US-20110294781-A1 | PYRAZOLO-PYRIMIDINE COMPOUNDS | AJINOMOTO CO., INC. (JP) | 2011-12-01 | — | — | US | disclosed |
| US-7727997-B2 | N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives | ELAN PHARMACEUTICALS, INC. (US) | 2010-06-01 | — | — | US | disclosed |
| US-7727997-B2 | N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives | ELAN PHARMACEUTICALS, INC. (US) | 2010-06-01 | — | — | US | disclosed |
| US-5234946-A | Anticholesterol, antilipemic | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1993-08-10 | — | — | US | disclosed |
| US-5233047-A | Benzotriazole UV absorber hydrazides | ELF ATOCHEM NORTH AMERICA, INC. (US) | 1993-08-03 | — | — | US | disclosed |
| US-5231249-A | Olefin polymer crosslinked with (tert-butylperoxyisopropyl)-isopropylbenzene | THE FURUKAWA ELECTRIC CO., LTD. (JP) | 1993-07-27 | — | — | US | disclosed |
| EP-0318860-B1 | SUBSTITUTED ALKYLAMINE DERIVATIVES | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1993-06-16 | — | — | EP | disclosed |
| EP-0469155-A1 | OLEFINIC RESIN COMPOSITION FOR POWER CABLE, AND POWER CABLE AND JUNCTION THEREOF MADE FROM SAID COMPOSITION | THE FURUKAWA ELECTRIC CO., LTD. (JP) | 1992-02-05 | — | — | EP | disclosed |
| EP-0409840-A4 | BENZOTRIAZOLE AND OXANILIDE UV ABSORBER HYDRAZIDES | — | 1991-09-04 | — | — | EP | disclosed |
| EP-0409840-A1 | BENZOTRIAZOLE AND OXANILIDE UV ABSORBER HYDRAZIDES | ELF ATOCHEM NORTH AMERICA, INC. (US) | 1991-01-30 | — | — | EP | disclosed |
| US-4980420-A | Benzotriazole and oxanilide UV absorber hydrazides | ATOCHEM NORTH AMERICA, INC. (US) | 1990-12-25 | — | — | US | disclosed |
| WO-1990009369-A1 | BENZOTRIAZOLE AND OXANILIDE UV ABSORBER HYDRAZIDES | ATOCHEM NORTH AMERICA, INC. (US) | 1990-08-23 | — | — | WO | disclosed |
| EP-0318860-A2 | Substituted alkylamine derivatives | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1989-06-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110294781-A1 | PYRAZOLO-PYRIMIDINE COMPOUNDS | IL23R, IL2, IL17A | UNG 3284/4885ALDH1A1 1291/4885TRIM24 459/4885 |
| US-20120323002-A1 | IMIDAZOPYRIDAZINE COMPOUNDS | IL23R, IL15, IL5 | UNG 4513/4885ALDH1A1 361/4885TRIM24 167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.